[1] |
PATEL S G, KARLITZ J J, YEN T, et al. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection[J]. Lancet Gastroenterol Hepatol, 2022, 7(3): 262-274.
doi: 10.1016/S2468-1253(21)00426-X
|
[2] |
BENSON A B, VENOOK A P, AL-HAWARY M M, et al. NCCN guidelines insights: colon cancer, version 2.2018[J]. J Natl Compr Canc Netw, 2018, 16(4): 359-369.
doi: 10.6004/jnccn.2018.0021
|
[3] |
MALIER M, GHARZEDDINE K, LAVERRIERE M H, et al. Hypoxia drives dihydropyrimidine dehydrogenase expression in macrophages and confers chemoresistance in colorectal cancer[J]. Cancer Res, 2021, 81(23): 5963-5976.
doi: 10.1158/0008-5472.CAN-21-1572
pmid: 34645611
|
[4] |
DE FALCO V, NATALICCHIO M I, NAPOLITANO S, et al. A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant[J]. Medicine, 2019, 98(21): e15759.
|
[5] |
DEAN L, KANE M. Fluorouracil therapy and DPYD genotype[M]. PRATT V M, SCOTT S A, PIRMOHAMED M, eds. Medical genetics summaries. . Bethesda (MD): National Center for Biotechnology Information (US); November 3, 2016.
|
[6] |
贾真真, 何双, 李扬扬, 等. 结直肠癌中DPD与LC3、P62表达的相关性及其临床意义[J]. 中国癌症杂志, 2022, 32(1): 24-33.
doi: 10.19401/j.cnki.1007-3639.2022.01.003
|
|
JIA Z Z, HE S, LI Y Y, et al. Correlations between expressions of DPD, LC3 and P62 in colorectal cancer and their clinical significance[J]. China Oncol, 2022, 32(1): 24-33.
|
[7] |
YU L, CHEN Y, TOOZE S A. Autophagy pathway: cellular and molecular mechanisms[J]. Autophagy, 2018, 14(2): 207-215.
doi: 10.1080/15548627.2017.1378838
pmid: 28933638
|
[8] |
DIKIC I, ELAZAR Z. Mechanism and medical implications of mammalian autophagy[J]. Nat Rev Mol Cell Biol, 2018, 19(6): 349-364.
doi: 10.1038/s41580-018-0003-4
|
[9] |
ISLAM M A, SOORO M A, ZHANG P H. Autophagic regulation of p62 is critical for cancer therapy[J]. Int J Mol Sci, 2018, 19(5): 1405.
doi: 10.3390/ijms19051405
|
[10] |
JIN H, SEO G S, LEE S H. Isoliquiritigenin-mediated p62/SQSTM1 induction regulates apoptotic potential through attenuation of caspase-8 activation in colorectal cancer cells[J]. Eur J Pharmacol, 2018, 841: 90-97.
doi: S0014-2999(18)30591-0
pmid: 30339814
|
[11] |
LAMARK T, SVENNING S, JOHANSEN T. Regulation of selective autophagy: the p62/SQSTM1 paradigm[J]. Essays Biochem, 2017, 61(6): 609-624.
doi: 10.1042/EBC20170035
pmid: 29233872
|
[12] |
SUN A Q, WEI J, CHILDRESS C, et al. The E3 ubiquitin ligase NEDD4 is an LC3-interactive protein and regulates autophagy[J]. Autophagy, 2017, 13(3): 522-537.
doi: 10.1080/15548627.2016.1268301
pmid: 28085563
|
[13] |
LEVINE B, KROEMER G. Biological functions of autophagy genes: a disease perspective[J]. Cell, 2019, 176(1/2): 11-42.
doi: 10.1016/j.cell.2018.09.048
|
[14] |
BONAM S R, TRANCHANT C, MULLER S. Autophagy-lysosomal pathway as potential therapeutic target in Parkinson's disease[J]. Cells, 2021, 10(12): 3547.
doi: 10.3390/cells10123547
|
[15] |
YANG Y, WANG Q, SONG D J, et al. Lysosomal dysfunction and autophagy blockade contribute to autophagy-related cancer suppressing peptide-induced cytotoxic death of cervical cancer cells through the AMPK/mTOR pathway[J]. J Exp Clin Cancer Res, 2020, 39(1): 197.
doi: 10.1186/s13046-020-01701-z
|
[16] |
LI J X, LIU G, LI L, et al. Research progress on the effect of autophagy-lysosomal pathway on tumor drug resistance[J]. Exp Cell Res, 2020, 389(2): 111925.
|
[17] |
XUAN Y, ZHAO S, XIAO X J, et al. Inhibition of chaperone-mediated autophagy reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer[J]. Mol Med Rep, 2021, 23(5): 360.
doi: 10.3892/mmr.2021.11999
|
[18] |
YANG J W, ZHANG Q H, LIU T. Autophagy facilitates anticancer effect of 5-fluorouracil in HCT-116 cells[J]. J Cancer Res Ther, 2018, 14(Supplement): S1141-S1147.
|
[19] |
TOZER T, HEALE K, MANTO CHAGAS C, et al. Interdomain twists of human thymidine phosphorylase and its active-inactive conformations: binding of 5-FU and its analogues to human thymidine phosphorylase versus dihydropyrimidine dehydrogenase[J]. Chem Biol Drug Des, 2019, 94(5): 1956-1972.
doi: 10.1111/cbdd.13596
pmid: 31356728
|
[20] |
SHARMA V, GUPTA S K, VERMA M. Dihydropyrimidine dehydrogenase in the metabolism of the anticancer drugs[J]. Cancer Chemother Pharmacol, 2019, 84(6): 1157-1166.
doi: 10.1007/s00280-019-03936-w
|
[21] |
ZHANG Y H, SHI W N, WU S H, et al. SphK2 confers 5-fluorouracil resistance to colorectal cancer via upregulating H3K56ac-mediated DPD expression[J]. Oncogene, 2020, 39(29): 5214-5227.
doi: 10.1038/s41388-020-1352-y
|
[22] |
ZHANG Y H, LUO D D, WAN S B, et al. S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancer[J]. Pharmacol Res, 2020, 155: 104717.
|
[23] |
YOSHII S R, MIZUSHIMA N. Monitoring and measuring autophagy[J]. Int J Mol Sci, 2017, 18(9): 1865.
doi: 10.3390/ijms18091865
|
[24] |
OZATES N P, SOĞUTLU F, LERMINOGLU F, et al. Effects of rapamycin and AZD3463 combination on apoptosis, autophagy, and cell cycle for resistance control in breast cancer[J]. Life Sci, 2021, 264: 118643.
|
[25] |
ZHANG J, MAO W, LIU Y Y, et al. 3-MA enhanced chemosensitivity in cisplatin resistant hypopharyngeal squamous carcinoma cells via inhibiting beclin-1 mediated autophagy[J]. Curr Pharm Des, 2021, 27(7): 996-1005.
doi: 10.2174/1381612826666201221150431
|
[26] |
LIU L Q, WANG S B, SHAO Y F, et al. Hydroxychloroquine potentiates the anti-cancer effect of bevacizumab on glioblastoma via the inhibition of autophagy[J]. Biomedecine Pharmacother, 2019, 118: 109339.
|
[27] |
ZAMAME RAMIREZ J A, ROMAGNOLI G G, KANENO R. Inhibiting autophagy to prevent drug resistance and improve anti-tumor therapy[J]. Life Sci, 2021, 265: 118745.
|
[28] |
LI J, HOU N, FARIED A, et al. Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model[J]. Eur J Cancer, 2010, 46(10): 1900-1909.
doi: 10.1016/j.ejca.2010.02.021
pmid: 20231086
|
[29] |
CHOI J H, YOON J S, WON Y W, et al. Chloroquine enhances the chemotherapeutic activity of 5-fluorouracil in a colon cancer cell line via cell cycle alteration[J]. APMIS, 2012, 120(7): 597-604.
doi: 10.1111/j.1600-0463.2012.02876.x
|
[30] |
LIU W J, YE L, HUANG W F, et al. p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation[J]. Cell Mol Biol Lett, 2016, 21: 29.
doi: 10.1186/s11658-016-0031-z
pmid: 28536631
|
[31] |
JOHANSEN T, LAMARK T. Selective autophagy mediated by autophagic adapter proteins[J]. Autophagy, 2011, 7(3): 279-296.
doi: 10.4161/auto.7.3.14487
pmid: 21189453
|
[32] |
ZHENG N, SHABEK N. Ubiquitin ligases: Structure, function, and regulation[J]. Annu Rev Biochem, 2017, 86: 129-157.
doi: 10.1146/annurev-biochem-060815-014922
pmid: 28375744
|